187 related articles for article (PubMed ID: 35686702)
1. Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump.
Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Engelmann C; Herber A; Trepte C; Capel J; De Gottardi A
Liver Int; 2022 Oct; 42(10):2247-2259. PubMed ID: 35686702
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
[TBL] [Abstract][Full Text] [Related]
3. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
Wong F; Bendel E; Sniderman K; Frederick T; Haskal ZJ; Sanyal A; Asrani SK; Capel J; Kamath PS
Liver Transpl; 2020 May; 26(5):651-661. PubMed ID: 31999044
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
5. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis.
Will V; Rodrigues SG; Berzigotti A
Dig Liver Dis; 2022 Aug; 54(8):1007-1014. PubMed ID: 35016859
[TBL] [Abstract][Full Text] [Related]
6. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
Salerno F; Cammà C; Enea M; Rössle M; Wong F
Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
[TBL] [Abstract][Full Text] [Related]
8. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
9. Automated low-flow ascites pump in a real-world setting: complications and outcomes.
Solbach P; Höner Zu Siederdissen C; Wellhöner F; Richter N; Heidrich B; Lenzen H; Kerstin P; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1082-1089. PubMed ID: 29738325
[TBL] [Abstract][Full Text] [Related]
10. Consensus care recommendations for alfapump
Aagaard NK; Malago M; De Gottardi A; Thomas M; Sauter G; Engelmann C; Aranovich D; Cohen M; Thévenot T; Ehmann T; Capel J; Angeli P; Jalan R; Stirnimann G
BMC Gastroenterol; 2022 Mar; 22(1):111. PubMed ID: 35260086
[TBL] [Abstract][Full Text] [Related]
11. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
12. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
[TBL] [Abstract][Full Text] [Related]
13. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
[TBL] [Abstract][Full Text] [Related]
14. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
15. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
Neong SF; Adebayo D; Wong F
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
[TBL] [Abstract][Full Text] [Related]
16. [Management of refractory ascites by the automated low flow pump system (Alfapump)].
Restellini S; Soares PC; Giostra E; Spahr L
Rev Med Suisse; 2014 Sep; 10(440):1607-8, 1610-1. PubMed ID: 25276999
[TBL] [Abstract][Full Text] [Related]
17. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
Shao J; Zhang L; Han GH; Fan DM
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
[TBL] [Abstract][Full Text] [Related]
18. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
19. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
20. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
Wang SZ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
